Amy L. Burroughs, Chief Executive Officer at Terns Pharmaceuticals, Inc. (TERN), bought 46,628 shares at $3.87 ($180K) on 2025-06-25, disclosed to the SEC on 2025-06-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.87 | 23,314 | $90K | 50.0% |
| 2 | $3.87 | 23,314 | $90K | 50.0% |
| Total | $3.87 avg | 46,628 | $180K | 100% |
| Filing → |
| TERN | SELL | 2026-01-16 | $5.1M | — | Filing → |
| TERN | SELL | 2026-01-06 | $5.4M | — | Filing → |
| TERN | BUY | 2025-02-03 | $3K | — | Filing → |